Stock Events

Stock Events

Lyra Therapeutics (LYRA) Q2 2025 Earnings

6MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-7.5

-5.04

-2.58

-0.12

Details

Expected EPS

-7.5

Actual EPS

-6.5

Surprise EPS

1

Surprise Percent

+13.33%

Description

Lyra Therapeutics (LYRA) has reported earnings of -6.5 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.